[Pathogenesis and treatment of congenital nephrogenic diabetes insipidus (author's transl)(proceedings)].
D001834:Body Water / Q000502:physiology; D003994:Bucladesine; D002740:Chlorothiazide / Q000627:therapeutic use; D000242:Cyclic AMP / Q000378:metabolism; D003919:Diabetes Insipidus / Q000151:congenital* / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D008297:Male; D013806:Theophylline / Q000627:therapeutic use; D014667:Vasopressins / Q000627:therapeutic use
D014667:Vasopressins; D003994:Bucladesine; D002740:Chlorothiazide; D013806:Theophylline; D000242:Cyclic AMP
Pathogénie et thérapeutique du diabète insipide néphrogénique. A propos de deux observations